Sitemap > Breaking Research > Cardiovascular Disorders
Displaying 1451 - 1500 of 4862 results
- Pharmacological characterisation of sodium channels in sinoatrial node pacemaking in the rat heart.
- The nonspecific anti-inflammatory therapy with methotrexate for patients with chronic heart failure.
- Valsartan inhibits platelet activity at different doses in mild to moderate hypertensives: Valsartan Inhibits Platelets (VIP) trial.
- A randomized pilot study of dalteparin versus unfractionated heparin during percutaneous coronary interventions.
- Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting.
- Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARbeta.
- The chemokines CXCL9 and CXCL10 promote a protective immune response but do not contribute to cardiac inflammation following infection with Trypanosoma cruzi.
- Percutaneous transluminal angioplasty in severe diabetic foot ischemia: outcomes and prognostic factors.
- Low dose amiodarone-induced lung injury.
- Tissue cardiomyoplasty using bioengineered contractile cardiomyocyte sheets to repair damaged myocardium: their integration with recipient myocardium.
- Automated drug delivery system to control systemic arterial pressure, cardiac output, and left heart filling pressure in acute decompensated heart failure.
- H11 kinase prevents myocardial infarction by preemptive preconditioning of the heart.
- A randomized comparison of pioglitazone to inhibit restenosis after coronary stenting in patients with type 2 diabetes.
- Impaired coronary endothelium-dependent vasodilation is associated with microalbuminuria in patients with type 2 diabetes and angiographically normal coronary arteries.
- Immune responses to an encapsulated allogeneic islet beta-cell line in diabetic NOD mice.
- New benzimidazoles as thrombopoietin receptor agonists.
- Soluble CD40 ligand and interleukin-6 in the coronary circulation after acute myocardial infarction.
- Comparative safety of atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients.
- Effect of Losartan and Amlodipine on Left Ventricular Diastolic Function in Patients With Mild-to-Moderate Hypertension (J-ELAN): rationale and design.
- Interferon gamma-inducible protein 10 selectively inhibits proliferation and induces apoptosis in endothelial cells.
- In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells.
- Discovery and synthesis of a novel series of quinoline-based thrombin receptor (PAR-1) antagonists.
- Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells.
- Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand.
- Does obesity induce resistance to the long-term cardiovascular and metabolic actions of melanocortin 3/4 receptor activation?
- Synergistic acceleration of arterial stiffening in the presence of raised blood pressure and raised plasma glucose.
- CD8+ T lymphocytes regulate the arteriogenic response to ischemia by infiltrating the site of collateral vessel development and recruiting CD4+ mononuclear cells through the expression of interleukin-16.
- Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice.
- Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial.
- The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers.
- Treatment of chemotherapy-induced anemia in breast cancer: results of a randomized controlled trial of darbepoetin alfa 200 microg every 2 weeks versus epoetin alfa 40,000 U weekly.
- Percutaneous isolated limb perfusion with thrombolytics for severe limb ischemia.
- Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells.
- Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis.
- Sirolimus as an alternative to anticalcineurin therapy in heart transplantation: experience of a single center.
- Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.
- Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999 to 2002.
- Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.
- Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
- Use of FTY 720 and ICAM-1 antisense oligonucleotides for attenuating chronic renal damage secondary to ischemia-reperfusion injury.
- Phosphodiesterase 5 inhibition in chronic heart failure and pulmonary hypertension.
- Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE.
- Prognostic value of ventricular arrhythmias and heart rate variability in patients with unstable angina.
- Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care.
- Astrocyte-mediated control of cerebral blood flow.
- Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome.
- Activation of the calcineurin signaling pathway induces atrial hypertrophy during atrial fibrillation.
- Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss.
- Antihypertensive medication use among US adults with hypertension.
- L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial.
< Previous 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 Next >